Want to see URGN full AI Analyst Report?
Urogen Pharma (URGN) Revenue
Urogen Pharma Revenue
Urogen Pharma had a revenue of 72.46M in the quarter ending Jun 30, 2026, with 42.18%. This bring the company's revenue in the last twelve months to 188.73M, Increased 34.34%. In the fiscal year ending Dec 31, 2025, Urogen Pharma had annual revenue of 109.79M with 21.45% growth.
- Revenue (ttm)
- 188.73M
- Revenue Growth
- 100.27%
- P/S Ratio
- 14.57
- Revenue/Employee
- $365,960
- Employees
- 300
- Market Cap
- $1.60B
Revenue Chart
Urogen Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.79M | 19.39M | 21.45% |
| Dec 31, 2024 | 90.40M | 7.68M | 9.29% |
| Dec 31, 2023 | 82.71M | 18.36M | 28.52% |
| Dec 31, 2022 | 64.36M | 16.32M | 33.96% |
| Dec 31, 2021 | 48.04M | 36.24M | 307.17% |
| Dec 31, 2020 | 11.80M | 11.78M | 65450.00% |
| Dec 31, 2019 | 18.00K | -1.11M | -98.40% |
| Dec 31, 2018 | 1.13M | -7.03M | -86.17% |
| Dec 31, 2017 | 8.16M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.